Katy Beckermann, MD, PHD

Assistant Professor
Vanderbilt

Dr. Katy Beckermann is an Assistant Professor of Medicine at Vanderbilt-Ingram Cancer Center in Nashville, TN. Her passion is to advance the care of patients with kidney cancer through clinical trials and drug development. She is devoted to translational biomarker research with the goal this will ultimately allow treatment selection for patients.

Poster(s):

• 47: A Phase 1b Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PY314 In Combination with Pembrolizumab in Subjects with Advanced Solid Tumors, RCC cohort